Latest Stereotactic surgery Stories
SUNNYVALE, Calif., Nov. 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Piper Jaffray Healthcare Conference in New York on Wednesday, November 28, 2012 at 8:30 a.m. EST/5:30 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the...
TOKYO, Nov. 20, 2012 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the leading manufacturer of medical devices for treating cancer, will exhibit the company's advanced technologies for image-guided radiotherapy and radiosurgery at the 25(th) Annual Meeting of the Japanese Society for Therapeutic Radiology and Oncology (JASTRO) here later this week. During the meeting, Varian will also sponsor a luncheon seminar on the latest developments in stereotactic radiosurgery...
SUNNYVALE, Calif., Nov. 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Lazard Capital Markets Healthcare Conference in New York on Tuesday, November 13, 2012 at 3:30 p.m. EST/12:30 p.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast...
SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife(®) M6((TM)) Series. The CyberKnife M6 Series features expanded clinical capabilities, reduced treatment times and an enhanced patient experience. The new CyberKnife M6 FIM and FM Systems, featuring the InCise(TM) Multileaf...
BOSTON, Oct. 31, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) highlighted the company's technologies for the non-invasive treatment of lung cancer at the 54(th) annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston this week. Many of Varian's cancer treatment systems can be utilized for attacking lung tumors--which often move during treatment--very precisely, with carefully-shaped, high dose X-ray beams. "Our latest treatment systems have...
CLEVELAND, Oct. 31, 2012 /PRNewswire/ -- A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options. Rod Ellis, MD, lead author of the study along with Lee Ponsky, MD, who...
SHREWSBURY, England, October 29, 2012 /PRNewswire/ -- Continued Collaboration with Leading Clinical and Research University Hospital Provides Leading-Edge Research in Clinical Radiation Oncology Workflow Oncology Systems Limited UK (OSL), innovators in radiation therapy solutions, announced today the signing of a multi-year research and collaboration agreement with The UHB Radiotherapy Department and the Medical Physics Department. UHB researchers play a vital role in...
BOSTON, Oct. 29, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) yesterday unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...
BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) today unveiled its next move against cancer, the new EDGE(TM) Radiosurgery Suite(*) -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "Our new EDGE radiosurgery suite represents the first really disruptive technology in radiosurgery in close to two decades, combining...
SUNNYVALE, Calif. and BOSTON, Oct. 28, 2012 /PRNewswire/ -- ASTRO 2012 -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today launched its new TomoTherapy® H(TM) Series, featuring the TomoHDA(TM) System, with faster planning, faster delivery and increased quality. The TomoHDA System was unveiled at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston. Key features of the TomoHDA System include: Accuray's new...
